Axis 2
Studiedness
- Evidence amount
- 0.96
- Direction balance
- The direction of the study results has not been extracted.
- PMID records loaded
- 9
- Records after title/year deduplication
- 9
entity · release 2026-09-20
Lacticaseibacillus rhamnosus SP-1
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Across the corpus
How this organism is actually sold
- Forms
- Capsule: 1 · Powder: 1 · counted across the 2 of 2 published products whose label states a form
- Brands carrying it
- care-of (1) · laneinnovative (1)
- Published product pages
- 2
Products
Published products carrying this organism
| Product | Printed CFU | Printed dose | Cost per day | Form | Gut Index Score |
|---|---|---|---|---|---|
| care/of Pocket Protector | not printed | not printed | not observed | Powder | 72.78 |
| LaneInnovative Kefiran | not printed | not printed | not observed | Capsule | 57.29 |
Containing labels2
Evidence amount0.96
Direction balanceThe direction of the study results has not been extracted.
Matched PubMed records
9 records (retracted records excluded; 0 retracted records match the query separately). PubMed query
Matched records include trials of multi-ingredient products; this is not a count of trials of this entity alone.
- 2026 · Effect of probiotic supplementation on the progression of non-cavitated carious lesions in children: A 12-month randomized controlled trial.
- 2023 · Influence of mechanical debridement with adjunct probiotic therapy on clinical status and salivary cortisol levels in patients with periodontal inflammation.
- 2022 · Nasal administration of a probiotic assemblage in allergic rhinitis: A randomised placebo-controlled crossover trial.
- 2021 · Clinical effects of probiotic or azithromycin as an adjunct to scaling and root planning in the treatment of stage III periodontitis: a pilot randomized controlled clinical trial.
- 2021 · The consumption of milk supplemented with probiotics decreases the occurrence of caries and the salivary concentration of hβD-3 in children.
- 2019 · Severity of Candida-associated denture stomatitis is improved in institutionalized elders who consume Lactobacillus rhamnosus SP1.
- 2018 · Microbiological and clinical effects of probiotics and antibiotics on nonsurgical treatment of chronic periodontitis: a randomized placebo- controlled trial with 9-month follow-up.
- 2016 · Clinical Effects of Lactobacillus rhamnosus in Non-Surgical Treatment of Chronic Periodontitis: A Randomized Placebo-Controlled Trial With 1-Year Follow-Up.
- 2016 · Probiotic Compared with Standard Milk for High-caries Children: A Cluster Randomized Trial.
ClinicalTrials.gov
5 interventional studies. ClinicalTrials.gov query
This species has 57 tracked designations; this one appears on 2 labels (median 4).
Other printed names
- Lacticaseibacillus rhamnosus SP1
Species and related strains
Axis 1 · inverted
Containing label versions
Showing 2 of 2 rows, ordered by Gut Index Score descending, then DSLD label ID. Download full CSV · Download full JSON.
| Brand | Product | DSLD | Gut Index Score | Strain named | Per-organism quantity | Potency basis | Versions |
|---|---|---|---|---|---|---|---|
| care/of | Pocket Protector | 240794 | 72.78 | true | not printed for this organism | not stated | 1 |
| LaneInnovative | Kefiran | 263545 | 57.29 | true | not printed for this organism | through expiry | 1 |
Axis 3
Measurement integrity
Not a measurement product, so this axis does not apply.
Axis 4
Reddit mention panel
0 observed mentions; no aggregate panel matched this entity.
Elsewhere in this release
Related pages
Findings computed over the whole corpus: Strain naming census · Label designation changes · Strain dose match · Stability literature gaps
Tools: DSLD product check · Unit value calculator
Citation
Cite this page
Ivitskiy, I. (2026). Lacticaseibacillus rhamnosus SP-1. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/s/lacticaseibacillus-rhamnosus-sp-1/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Release claims
Lacticaseibacillus rhamnosus SP-1 appears on 2 of 13,330 labels in the NIH DSLD snapshot (Sep 2026), from 2 brands; tied with 91 designations by distinct label count.
2 / 13330 observed label versions · NIH DSLD snapshot Sep 2026 · entity.prevalence · checked 2026-09-20T00:00:00Z · snapshot b7633f7324370 of 2 containing labels in the NIH DSLD snapshot (Sep 2026) print a quantity for Lacticaseibacillus rhamnosus SP-1 (0.0%); 0 light records have quantities unavailable.
0 / 2 containing labels · NIH DSLD snapshot Sep 2026 · entity.quantity · checked 2026-09-20T00:00:00Z · snapshot b7633f7324379 PubMed records indexed as human randomized controlled trials match the published query (as of 2026-09-15). 9 records (retracted records excluded; 0 retracted records match the query separately).
9 / 9 loaded PMID records · NIH DSLD snapshot Sep 2026 · entity.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f7324375 interventional studies on ClinicalTrials.gov match the published query.
Published ClinicalTrials.gov query
5 / Not available in this release. interventional registry studies · NIH DSLD snapshot Sep 2026 · entity.registered_trials · checked 2026-09-20T00:00:00Z · snapshot b7633f7324370 of 2 SKUs containing Lacticaseibacillus rhamnosus SP-1 have a numeric price observation (0.0%) in the release accompanying the NIH DSLD snapshot Sep 2026.
0 / 2 containing SKUs · NIH DSLD snapshot Sep 2026 · entity.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437